Analyst Ratings for Eli Lilly (LLY) [Neutrals]
LLY Rating Summary
LLY Price Target Summary
- Highest: $722.00 (Morgan Stanley)
- Lowest: $270.00 (Atlantic Equities)
- Average: $580.95
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$580.95 (-2.9%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
Avg. $ Target:
$580.95 (-2.9%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/9/2023 | Deutsche Bank | James Shin | New Coverage | Hold (N/A) |
535.00 (N/A) |
599.93 (598.05) |
-0.31% | Details |
| 12/17/2021 | Goldman Sachs » Updated 8/9/2023 |
Chris Shibutani | New Coverage | Neutral (N/A) |
470.00 (385.00) |
279.04 (598.05) |
114.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
